Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
D000328:Adult; D001288:Attention / Q000187:drug effects; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D006220:Haloperidol / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000494:pharmacology / Q000627:therapeutic use; D007659:Ketones / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012919:Social Behavior / Q000187:drug effects; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology / Q000627:therapeutic use*
D001562:Benzimidazoles; D006846:Hydrocarbons, Halogenated; D007659:Ketones; D010880:Piperidines; D014149:Tranquilizing Agents; D006220:Haloperidol